|Last Price||Today's Change||52-Week Range||Trading Volume|
|59.30||0.44 (+0.74%)||46.30 - 59.72||1.5 million (Below Avg)|
Market data as of 11:40AM 11/28/14. Quotes are delayed by at least 15 min.
Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types
11/24/2014 8:59 AM ET
Allied-Bristol Life Sciences Forms Strategic Partnership with Synergy Partners R&D Solutions to Advance Biopharmaceutical Innovations From Leading U.S. Academic Research Institutions
11/18/2014 2:00 AM ET